跳至主要内容
临床试验/NCT02484040
NCT02484040Unknown3 期

Two-Week COurse Versus Conventionally Fractionated Preoperative Chemoradiotherapy In Locally Advanced Rectal Cancer (TwoArc Trial): A Phase III Randomized Clinical Trial

Jong Hoon Lee1 个研究点 分布在 1 个国家目标入组 370 人开始时间: 2015年12月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
发起方
Jong Hoon Lee
入组人数
370
试验地点
1
主要终点
Tumor response from stage II-III to stage 0-I

研究概览

简要总结

The investigators compare two-week course of chemoradiation (33 Gy in 10 fractions with oral capecitabine) and conventional chemoradiation (50.4 Gy in 28 fractions with 5-FU and leucovorin) in this randomized trial.

详细描述

1.1 experimental arm Two-week course concurrent chemoradiotherapy

  • Radiotherapy, 33 Gy/10 fractions for 2 weeks

↓↓↓↓↓ ↓↓↓↓↓ Radical surgery 6 weeks after completion of chemoradiotherapy D1----------------------D12

  • Capecitabine 825 mg/m2, twice daily

1.2 control arm

Standard concurrent chemoradiotherapy (CRT)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • histologically confirmed adenocarcinoma;
  • distal margin of the tumor located < 10 cm from the anal verge;
  • cT3-4N0-2 classification as determined by magnetic resonance imaging (MRI) and/or endorectal ultrasonography (EUS);
  • no evidence of distant metastasis;
  • Karnofsky performance score over 70;
  • adequate bone marrow, liver, and renal function (leucocytes >4000/mm3, hemoglobin >10 g/dL, platelets >100,000/mm3; serum bilirubin <1.5 mg/dL, serum transaminase <2.5 times the upper normal limit; serum creatinine <1.5 mg/dL).

排除标准

  • Metastatic disease
  • No complete resection of tumor (R2)

研究组 & 干预措施

Two-week course arm

Experimental

Experimental arm receive 33 Gy in 10 fractions of radiation for 2 weeks with oral capecitabine.

Two-week course of radiation, 33 Gy/10 fx and oral capecitabine, 825 mg/m2, bid

干预措施: Two-week course of radiation (Drug)

结局指标

主要结局

Tumor response from stage II-III to stage 0-I

时间窗: from clinical staging time to radical surgery date (about 3 months)

Downstaging rate was evaluated by comparing pre-clinical and post-CRT pathological stages, and downstaging was defined as ypStage 0-I (ypT0-2N0M0)

次要结局

  • Toxicity (acute and chronic)(from radiation start to 3 years after radical surgery)
  • Recurrence and survival(3-year recurrence-free survival and 3-year overall survival)

研究者

发起方
Jong Hoon Lee
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Jong Hoon Lee

Mr.

Seoul St. Mary's Hospital

研究点 (1)

Loading locations...

相似试验